Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting. - Pankert, Mathieu; Quilici, Jacques; Loundou, Anderson Diendonné; Verdier, Valentine; Lambert, Marc; Deharo, Pierre; Bonnet, Guillaume; Gaborit, Bénédicte; Morange, Pierre Emmanuel; Valéro, René; Dutour, Anne; Bonnet, Jean-Louis; et al. (American Journal of Cardiology, 2014)